Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(3)

Detailed Status

Completed3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

completed3100%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

DOuble tasK Test On ergometeR - Basic Research on Acceptability and Use

NCT03800771
completednot_applicable

Adaptation of the STEPPING ON Fall Prevention Program for Older Adults Receiving Cancer Therapy

NCT02737839
completed

Measurement of Gait Using Opal APDM and Gait Mat in Parkinsonism

NCT02064543

Clinical Trials (3)

Showing 3 of 3 trials
NCT03800771Not Applicable

DOuble tasK Test On ergometeR - Basic Research on Acceptability and Use

Completed
NCT02737839Not Applicable

Adaptation of the STEPPING ON Fall Prevention Program for Older Adults Receiving Cancer Therapy

Completed
NCT02064543

Measurement of Gait Using Opal APDM and Gait Mat in Parkinsonism

Completed

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3